Aincobio LLC

HOUSTON, TX · Biotech · Private

Single-use cartridge and benchtop instrument that enriches microbial cells and removes host cell contaminants prior to metagenomic sequencing

Grants
$1.2M
4 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
1
0 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: A Microbial Enrichment Device to Reduce the Cost of Sequencing Metagenomes$225,000
Federal grantDepartment of Health and Human Services · Phase I · Rapid and automated detection of bloodborne pathogens for improved treatment and antimicrobial stewardship$302,714
Federal grantDepartment of Health and Human Services · Phase I · A scalable electrokinetic flow cytometer and cell sorter$357,081
Federal grantDepartment of Health and Human Services · Phase I · PA21259, SBIR, Phase I, Development of a rapid, direct from blood, phenotypic antimicrobial susceptibility assay$306,500
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3009MONTANA MOLECULAR, LLC——
3010ARGOS VISION INC.——
3011BACSTITCH DNA INC.——
3012Aincobio LLC——
3013VORTEX BIOTECHNOLOGY CORPORATION——
3014CIRCUMVENT PHARMACEUTICALS, INC.——
3015Recodagen LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 1
  • Method and Apparatus for Isolating and Detecting Biological and Other Particlesapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.